bispecific DNA-encoded IgG antibody (Inovio/The Wistar Institute/MedImmune)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebispecific DNA-encoded IgG antibody (Inovio/The Wistar Institute/MedImmune)
Drug Alias NameDMAb (Inovio/The Wistar Institute/MedImmune)DNA-delivered monoclonal antibodies (Inovio/The Wistar Institute/MedImmune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncMedimmune LlcThe Wistar Institute Of Anatomy And Biology
Active IndicationsN/A
Inactive IndicationsPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A